While these results provided limited support for the current pathogenic classification, we anticipate that as the All of Us Research Program reaches 1 million participants, we will be powered to clarify the association of these rare pathogenic mutations in GJB2 to cancer predisposition. The gene discussed is GJB2; the disease is cancer.